{"id":11424,"date":"2024-04-16T07:00:00","date_gmt":"2024-04-16T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/"},"modified":"2024-04-16T07:00:00","modified_gmt":"2024-04-16T05:00:00","slug":"irlab-presenterar-pa-redeye-investor-forum","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/","title":{"rendered":"IRLAB presenterar p\u00e5 Redeye Investor Forum"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>G\u00f6teborg, 16 april, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att presentera p\u00e5 Redeye Investor Forum den 18 april.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>P\u00e5 Redeye Investor Forum kommer f\u00f6retaget att presenteras av Viktor Siewertz, CFO p\u00e5 IRLAB, som kommer att h\u00e5lla en 12-minuterspresentation av f\u00f6retaget f\u00f6ljt av en 8-minuters Q&amp;A kl. 18.45. Evenemanget h\u00e5lls p\u00e5 Pigalle, S\u00f6dra Hamngatan 2A i G\u00f6teborg. Evenemanget livestreamas och kan ses i efterhand p\u00e5 eventets hemsida.<\/p>\n<p>Presentationen kan f\u00f6ljas live p\u00e5 f\u00f6ljande l\u00e4nk: <a href=\"https:\/\/redeye-dot-yamm-track.appspot.com\/2spF4bldxyFLYICfMfPB7vHmkDkgLMtXLdxoAzjEUTH5RSOfCjgH6VkZTzD75GWK-iioeipXhxjWpgbb4kP6X5M1x5jBZ7OdjlJcEvMJQ7lTxCdXKdCVGUP0-SguE3K2eGGUFWBnbM-KbdQ4oktEPm2Bqru7-TqYVReiamEGX2BqOM1Zcf107g-VpO5uGIBY90bi46FM-1Kepm6A\" rel=\"noopener\" target=\"_blank\">https:\/\/www.redeye.se\/events\/972690\/investor-forum-goteborg-10<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-55a66492c4b4\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information<\/strong><\/p>\n<hr \/>\n<p>Viktor Siewertz, CFO<br \/>Tel: +46 727 10 70 70<br \/>E-post:\u00a0<a href=\"mailto:viktor.siewertz@irlab.se\" rel=\"noopener\" target=\"_blank\">viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-a19a8f82b785\">\n<p><strong class=\"mfn-heading-1\">Om IRLAB<\/strong><\/p>\n<hr \/>\n<p>IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan hj\u00e4rnans signalsubstanser och CNS-st\u00f6rningar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. Dessutom utvecklar bolaget \u00e4ven de tre prekliniska programmen IRL757 (med finansiering fr\u00e5n Michael J. Fox Foundation), IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0<a href=\"http:\/\/www.irlab.se\/\" rel=\"noopener\" target=\"_blank\">www.irlab.se<\/a>.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr \/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/0100fb1f-d060-4676-890f-1089383de12e\/irlab-presenterar-pa-redeye-investor-forum.pdf\" rel=\"noopener\" target=\"_blank\">IRLAB presenterar p\u00e5 Redeye Investor Forum<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>G\u00f6teborg, 16 april, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att presentera p\u00e5 Redeye Investor Forum den 18 april.<\/p>\n","protected":false},"template":"","class_list":["post-11424","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-presentation_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, 16 april, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att presentera p\u00e5 Redeye Investor Forum den 18 april.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/\",\"name\":\"IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-04-16T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar p\u00e5 Redeye Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB","og_description":"G\u00f6teborg, 16 april, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att presentera p\u00e5 Redeye Investor Forum den 18 april.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/","name":"IRLAB presenterar p\u00e5 Redeye Investor Forum - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-04-16T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-redeye-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar p\u00e5 Redeye Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}